UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characteristics of Mitochondrial Transformation into Human Cells

Scientific reports, 2016-05, Vol.6 (1), p.26057-26057, Article 26057

2016

Volltextzugriff (PDF)

Therapeutic potency of IL2–caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease

Gut, 2009-06, Vol.58 (6), p.790-798

2009

Volltextzugriff (PDF)

Surface antigens/receptors for targeted cancer treatment: the GnRH receptor/binding site for targeted adenocarcinoma therapy

Current cancer drug targets, 2004-12, Vol.4 (8), p.673-687

2004

Volltextzugriff (PDF)

GnRH-Bik/Bax/Bak chimeric proteins target and kill adenocarcinoma cells; the general use of pro-apoptotic proteins of the Bcl-2 family as novel killing components of targeting chimeric proteins

Apoptosis (London), 2000-12, Vol.5 (6), p.531

2000

Volltextzugriff (PDF)

Apoptosis-Inducing Human-Origin Fcε-Bak Chimeric Proteins for Targeted Elimination of Mast Cells and Basophils: A New Approach for Allergy Treatment

The Journal of immunology (1950), 2001-10, Vol.167 (8), p.4719-4728

2001

Volltextzugriff (PDF)

Cytotoxic Activity of an Interleukin 2--Pseudomonas Exotoxin Chimeric Protein Produced in Escherichia coli

Proceedings of the National Academy of Sciences - PNAS, 1988-03, Vol.85 (6), p.1922-1926

1988

Volltextzugriff (PDF)

Chimeric Cytotoxin IL2-PE40 Delays and Mitigates Adjuvant-Induced Arthritis in Rats

Proceedings of the National Academy of Sciences - PNAS, 1989-01, Vol.86 (1), p.287-291

1989

Volltextzugriff (PDF)

Cardiac Allograft Survival in Mice Treated with IL-2-PE40

Proceedings of the National Academy of Sciences - PNAS, 1989-02, Vol.86 (3), p.1008-1012

1989

Volltextzugriff (PDF)

Interleukin 2 (IL2) PE40 is cytotoxic to cells displaying either the p55 or p70 subunit of the IL2 receptor

The Journal of biological chemistry, 1988-12, Vol.263 (35), p.18650-18656

1988

Volltextzugriff (PDF)

Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-α, IL-6 and IL-1β: possible relevance to multiple sclerosis

Journal of neuroimmunology, 2003-05, Vol.138 (1), p.115-122

2003

Volltextzugriff (PDF)

Targeted Fc2′‐3‐PE40 chimeric protein abolishes passive cutaneous anaphylaxis in mice

Clinical and experimental immunology, 2000-03, Vol.119 (3), p.398-403

2000

Volltextzugriff (PDF)

Utilizing Fcε-Bak chimeric protein for studying IgE–FcεRI interactions

Clinical immunology (Orlando, Fla.), 2004, Vol.110 (1), p.89-99

2004

Volltextzugriff (PDF)

B-Cell Non-Hodgkin's Lymphoma: Evidence for the t(14;18) Translocation in All Hematopoietic Cell Lineages

JNCI : Journal of the National Cancer Institute, 1996-07, Vol.88 (14), p.973-979

1996

Volltextzugriff (PDF)

Using Apoptosis for Targeted Cancer Therapy by a New Gonadotropin Releasing Hormone-DNA Fragmentation Factor 40 Chimeric Protein

Clinical cancer research, 2003-03, Vol.9 (3), p.1179-1190

2003

Volltextzugriff (PDF)

Interleukin 2-Bax: a novel prototype of human chimeric proteins for targeted therapy

FEBS letters, 1999-08, Vol.457 (2), p.271-276

1999

Volltextzugriff (PDF)

Mechanism of action of interleukin-2 (IL-2)-Bax, an apoptosis-inducing chimaeric protein targeted against cells expressing the IL-2 receptor

Biochemical journal, 2003-02, Vol.370 (Pt 1), p.129-140

2003

Volltextzugriff (PDF)

Interleukin-2 (IL-2) receptor alpha, beta and gamma subunit expression as a function of B-cell lineage ontogeny: the use of IL-2-PE66(4Glu) to characterize internalization via IL-2 receptor subunits

Scandinavian journal of immunology, 1997-08, Vol.46 (2), p.129-136

1997

Volltextzugriff (PDF)

Overcoming Multidrug Resistance in Cancer Using Targeted Chimeric Proteins

Clinical immunology (Orlando, Fla.), 2009-01, Vol.131, p.S71-S71

2009

Volltextzugriff (PDF)

I.V. Administration of L‐GNRH‐PE66 efficiently inhibits growth of colon adenocarcinoma xenografts in nude mice

International journal of cancer, 2001-04, Vol.92 (2), p.263-268

2001

Volltextzugriff (PDF)

Selective immunosuppression of activated T cells with the chimeric toxin IL-2-PE40. Inhibition of experimental autoimmune uveoretinitis

The Journal of immunology (1950), 1989-12, Vol.143 (11), p.3498-3502

1989

Volltextzugriff (PDF)

Protein replacement therapy for mitochondrial disorders

Mitochondrion, 2015-09, Vol.24, p.S35

2015

Volltextzugriff (PDF)

Adenocarcinoma Cells Are Targeted by the New GnRH-PE66 Chimeric Toxin through Specific Gonadotropin-releasing Hormone Binding Sites

The Journal of biological chemistry, 1997-04, Vol.272 (17), p.11597-11603

1997

Volltextzugriff (PDF)

Utilizing a GnRH-based chimeric protein for the detection of adenocarcinoma

International journal of oncology, 2005-07, Vol.27 (1), p.143

2005

Volltextzugriff (PDF)

Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury

International journal of experimental pathology, 2005-10, Vol.86 (5), p.279-288

2005

Volltextzugriff (PDF)

IL-2-PE40 is cytotoxic for activated T lymphocytes expressing IL-2 receptors

The Journal of immunology (1950), 1988-12, Vol.141 (12), p.4224-4228

1988

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(34)
Animals
(26)
Biological And Medical Sciences
(23)
Humans
(22)
Mice
(18)
Medical Sciences
(16)
Adp Ribose Transferases
(15)
Immunology
(14)
Exotoxins - Pharmacology
(13)
Female
(13)
Interleukin-2 - Pharmacology
(13)
Recombinant Fusion Proteins - Pharmacology
(13)
Cell Line
(12)
Pseudomonas Aeruginosa Exotoxin A
(12)
Virulence Factors
(12)
Apoptosis
(10)
Bacterial Toxins
(10)
Pseudomonas
(9)
Male
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characteristics of Mitochondrial Transformation into Human Cells

Therapeutic potency of IL2–caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease

Surface antigens/receptors for targeted cancer treatment: the GnRH receptor/binding site for targeted adenocarcinoma therapy

GnRH-Bik/Bax/Bak chimeric proteins target and kill adenocarcinoma cells; the general use of pro-apoptotic proteins of the Bcl-2 family as novel killing components of targeting chimeric proteins

Apoptosis-Inducing Human-Origin Fcε-Bak Chimeric Proteins for Targeted Elimination of Mast Cells and Basophils: A New Approach for Allergy Treatment

Cytotoxic Activity of an Interleukin 2--Pseudomonas Exotoxin Chimeric Protein Produced in Escherichia coli

Chimeric Cytotoxin IL2-PE40 Delays and Mitigates Adjuvant-Induced Arthritis in Rats

Cardiac Allograft Survival in Mice Treated with IL-2-PE40

Interleukin 2 (IL2) PE40 is cytotoxic to cells displaying either the p55 or p70 subunit of the IL2 receptor

Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-α, IL-6 and IL-1β: possible relevance to multiple sclerosis

Targeted Fc2′‐3‐PE40 chimeric protein abolishes passive cutaneous anaphylaxis in mice

Utilizing Fcε-Bak chimeric protein for studying IgE–FcεRI interactions

B-Cell Non-Hodgkin's Lymphoma: Evidence for the t(14;18) Translocation in All Hematopoietic Cell Lineages

Using Apoptosis for Targeted Cancer Therapy by a New Gonadotropin Releasing Hormone-DNA Fragmentation Factor 40 Chimeric Protein

Interleukin 2-Bax: a novel prototype of human chimeric proteins for targeted therapy

Mechanism of action of interleukin-2 (IL-2)-Bax, an apoptosis-inducing chimaeric protein targeted against cells expressing the IL-2 receptor

Interleukin-2 (IL-2) receptor alpha, beta and gamma subunit expression as a function of B-cell lineage ontogeny: the use of IL-2-PE66(4Glu) to characterize internalization via IL-2 receptor subunits

Overcoming Multidrug Resistance in Cancer Using Targeted Chimeric Proteins

I.V. Administration of L‐GNRH‐PE66 efficiently inhibits growth of colon adenocarcinoma xenografts in nude mice

Selective immunosuppression of activated T cells with the chimeric toxin IL-2-PE40. Inhibition of experimental autoimmune uveoretinitis

Protein replacement therapy for mitochondrial disorders

Adenocarcinoma Cells Are Targeted by the New GnRH-PE66 Chimeric Toxin through Specific Gonadotropin-releasing Hormone Binding Sites

Utilizing a GnRH-based chimeric protein for the detection of adenocarcinoma

Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury

IL-2-PE40 is cytotoxic for activated T lymphocytes expressing IL-2 receptors

Suchergebnisse filtern